All had autoantibodies against IFN-ω and NACHT leucine-rich repeat protein 5 (NALP5), and the median number of autoantibodies was 6 (range, 4–8) of a panel of 14 APS-1–related autoantibodies (17). This evidence concerns the gene NLRP5 and autoimmune polyendocrine syndrome type 1.